CGRP (8-37), human

CGRP (8-37), human, is a synthetic peptide fragment derived from the human calcitonin gene-related peptide (CGRP), specifically comprising amino acid residues 8 through 37 of the native sequence. As a truncated analog, it functions as a potent and selective antagonist of the CGRP receptor, a G protein-coupled receptor involved in diverse physiological processes, including vasodilation, nociception, and neurogenic inflammation. Due to its ability to competitively inhibit the binding of endogenous CGRP, this peptide holds significant value in research aimed at dissecting the roles of CGRP signaling in both central and peripheral tissues. Its distinctive structure and receptor selectivity make it an indispensable tool for mechanistic studies in neurobiology, cardiovascular research, and peptide pharmacology.

Receptor antagonism studies: As a well-characterized CGRP receptor antagonist, the peptide is widely employed in studies investigating the molecular mechanisms underlying CGRP-mediated signaling pathways. By selectively blocking receptor activation, researchers can delineate the specific contributions of endogenous CGRP in processes such as vasodilation, pain transmission, and neurogenic inflammation. This enables precise mapping of receptor function, facilitating a deeper understanding of the physiological and pathophysiological roles of CGRP in various organ systems.

Neurobiology research: The ability of CGRP (8-37) to modulate neuronal signaling pathways makes it a valuable reagent in neurobiological investigations. It is commonly used to explore the involvement of CGRP in synaptic transmission, sensory processing, and the modulation of neuronal excitability. By applying the peptide in in vitro or in vivo models, investigators can assess the impact of CGRP receptor blockade on neural circuits, advancing knowledge of neuropeptide function in the central and peripheral nervous systems.

Migraine and pain pathway modeling: Given the established role of CGRP in the pathophysiology of migraine and other pain syndromes, this peptide fragment serves as a critical tool in experimental models designed to elucidate the mechanisms of pain sensitization and headache generation. Researchers utilize it to inhibit CGRP signaling in animal or cellular models, thereby assessing the downstream effects on nociceptive pathways and identifying potential molecular targets for future pharmacological intervention.

Vascular biology and cardiovascular studies: The peptide's antagonistic activity at the CGRP receptor is leveraged in vascular biology to examine the regulatory effects of CGRP on blood vessel tone and endothelial function. By selectively blocking CGRP-mediated vasodilatory responses, scientists can investigate the contributions of this neuropeptide to vascular homeostasis, blood flow regulation, and the development of vascular disorders. Such studies are crucial for understanding the interplay between neuropeptide signaling and cardiovascular health.

Peptide pharmacology and structure-activity relationship analysis: CGRP (8-37) is also instrumental in peptide-based pharmacological research, particularly in studies aiming to define the structural determinants of receptor binding and antagonism. Its use in comparative assays with full-length CGRP and other analogs enables the identification of key sequence motifs responsible for receptor interaction. These insights inform the rational design of novel peptide antagonists and contribute to the broader field of peptide drug discovery and development.

1. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

2. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

3. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

4. Cationic cell-penetrating peptides are potent furin inhibitors

5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes